Latest / The Cracking Cancer Podcast
What’s the buzz around GLP-1s and cancer with Samantha Murrell and Rob Swanda, PhD? Episode 56.
The Metabolic Blueprint: Weighing the Evidence on GLP-1s and Cancer Survival
In this highly anticipated episode of Cracking Cancer, host Dr. Kyle Concannon sits down with patient advocate Samantha Murrell and science communicator Rob Swanda, PhD, to tackle the most talked-about presentation from the 2026 American Society of Clinical Oncology (ASCO) annual meeting: the intersection of GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) and oncology. Samantha reveals that she has been using an off-label microdose of a GLP-1 alongside her targeted therapy for Stage IV HER2-mutant lung…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.